Navigation Links
MicroPhage Selects Lynn Taussig, MD for Board of Directors
Date:12/2/2008

LONGMONT, Colo., Dec. 2 /PRNewswire/ -- MicroPhage, Inc., http://www.microphage.com, announced today that Lynn M. Taussig, MD has joined the company's Board of Directors. Taussig was president and CEO of National Jewish Medical and Research Center in Denver, the nation's leading institution for studying respiratory diseases, from 1993 to 2006. His medical specialty is pediatric pulmonology.

"I have followed MicroPhage extensively and am impressed with its progress in developing new, rapid bacterial identification and antibiotic susceptibility tests, and am enthused about the clinical impact their products will have in providing accurate and cost-effective diagnosis of serious infections," said Taussig.

MicroPhage CEO Steve Lundy knows Taussig's expertise in diagnosis and management of respiratory diseases and his healthcare management experience will be valuable to the board in guiding the company's future. "We are pleased to have a physician and hospital executive of Dr. Taussig's stature join our board. His involvement and support shows confidence in MicroPhage, and his clinical expertise and vision will be deeply valued," said Lundy.

Taussig has served on numerous academic, government and business boards and commissions and has authored more than 170 publications related to respiratory illnesses in children. He has earned several academic, civic and professional honors, including the Distinguished Achievement Award from the American Thoracic Society. He currently serves as special advisor to the Provost for Life Sciences at the University of Denver and is on the Board of Directors of the Colorado Biosciences Association.

MicroPhage is in late stage development for its bacterial detection and susceptibility diagnostic system. The first products are targeted for rapid detection of MRSA (methicillin-resistant Staphylococcus aureus) and MSSA (methicillin-sensitive Staphylococcus aureus) for screening and diagnostic applications.

About MicroPhage

Based in Longmont, Colo. and privately held, MicroPhage, Inc. is working to be a global leader in developing rapid diagnostics products for bacterial identification and antibiotic susceptibility/resistance testing. Using its bacteriophage-based amplification platform for immunoassay diagnostics, the company has developed a patented process that is a product platform or engine for rapid, easy-to-use, inexpensive bacterial identification and antibiotic susceptibility testing. Its first products, expected in late 2009, will set a new standard for clinicians in MRSA identification and antibiotic susceptibility testing, and are designed to fit the demands for improving laboratory workflow. For further information, go to http://www.microphage.com.


'/>"/>
SOURCE MicroPhage
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections
2. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
3. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
4. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
5. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
6. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
7. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
8. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
9. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
10. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
11. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited to ... dermatologist. Dr. Kim brings an extensive background in cutting-edge dermatology care and research ... to welcome back Dr. Kim to the CDG team” said President and Managing Partner ...
(Date:1/19/2017)... ... 19, 2017 , ... "ProParagraph Basics is a set of ... for all media productions," said Christina Austin - CEO of Pixel Film Studios. ... paragraphs designed for multi-lined text purposes. Choose from presets with basic, yet ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... of Proctology) announced today the opening of 3 medical offices specializing specifically ... Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center of Newport Beach, ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Delaware farmer Rick ... St. Louis, Missouri. , Dickerson, of Laurel, farms about a thousand acres of soybeans, ... yellow squash on contract and pumpkins and other vegetables for the fresh market. He ...
(Date:1/18/2017)... MD (PRWEB) , ... January 18, 2017 , ... ... of Maryland Fischell Department of Bioengineering are collaborating on a research project focused ... in bioengineering, the project seeks to use nanotechnology to control the disease without ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 18, 2017 The Global Therapy Partnering Terms ... to partnering deals and agreements entered into by the ... deals - Top deals by value - Deals listed ... type The report provides understanding and access to ... world,s leading healthcare companies. The report provides an ...
(Date:1/19/2017)... Va. , Jan. 18, 2017 ... the Food and Drug Administration (FDA) for its ... companies and population health decision makers can proactively ... approved products as well as emerging therapies awaiting ... largely mirrors consensus recommendations that AMCP developed during ...
(Date:1/18/2017)... and PUNE, India , January 18, ... Allied Market Research, titled, "Breast Imaging Technologies Market by Type: ... global breast imaging technologies market size was valued at $2,544 ... by 2022, growing at a CAGR of 8.4% from 2016 ... Europe together accounted for over three-fourths market ...
Breaking Medicine Technology: